1. Abbas A, Mirza MM, Ganti AK, Tendulkar K (2015) Renal toxicities of targeted therapies. Target Oncol 10:487–499
2. Adams LE, Roberts SM, Donovan-Brand R, Zimmer H, Hess EV (1993) Study of procainamide hapten-specific antibodies in rabbits and humans. Int J Immunopharmacol 15:887–897
3. Almanzar MM, Frazier KS, Dube PH, Piqueras AI, Jones WK, Charette MF, Paredes AL (1998) Expression of OP-1 is selectively modified after acute ischemic renal injury. J Am Soc Nephrol 9:1456–1463
4. Anders MW (1980) Metabolism of drugs in kidney. Kidney Int 18:636–647
5. Arts HH, Knoers VAM (2013) Current insights into renal ciliopathies: what can genetics teach us? Pediatr Nephrol 28:863–874